TL;DR
A DRLs signature capable of predicting the TMB, prognosis, and immunological cell infiltration patterns, as well as the reactions to immunotherapy in EC patients is developed.
AI-generated by Semantic Scholar
Authors
Lin Hong, Ya-Xing Fang, Tao Li, Yu-Feng He, Qin-Qin Jin, Xiao Xu, Shu-Guang Zhou
